SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
GigaDevice Semiconductor Inc. (03986) will fully exercise the oversubscribed rights issue, stabilize prices and end the stabilization period.
DYNAGREEN ENV(01330): "Green Dynamic Convertible Bond" will pay interest on February 25th.
LAUNCH TECH (02488): China Securities Regulatory Commission issues a filing notice for the company's H-share full circulation application.
GigaDevice Semiconductor Inc. (03986) will fully exercise the oversubscribed rights issue, stabilize prices and end the stabilization period.
DYNAGREEN ENV(01330): "Green Dynamic Convertible Bond" will pay interest on February 25th.
LAUNCH TECH (02488): China Securities Regulatory Commission issues a filing notice for the company's H-share full circulation application.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
